Helicobacter pylori culture as a key tool for diagnosis in Colombia

Keywords: Helicobacter pylori, Diagnosis, Cholesterol enriched culture, Rapid Urease Test, Human gastric biopsies


Introduction: The presence of H. pylori in the stomach is associated with gastric pathologies. However, its diagnosis through culture methods is challenging because of its complex nutritional requirements and microaerophilic conditions for optimal growth. The preferred method for rapid diagnosis of H. pylori is the Rapid Urease Test (RUT) from human biopsies, which relies on the high activity of the urease enzyme present in H. pylori. However, RUT cannot say much more information about H. pylori. This makes evident the need for bacterial culture to know essential information such as the strain type, the kind of infection present and the bacteria’s antibiotic susceptibility.

Methodology: Gastric biopsies from 347 patients were used for H. pylori isolation. We correlated the culture results with the RUT and histological grading used at Hospital Universitario Fundación SantaFe de Bogotá (HU-FSFB), Colombia. The concordance between techniques was determined by the Cohen’s Kappa coefficient (K). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were also calculated.

Results: The culture standardization was successful, and it could be applied for diagnosis in the clinical practice. H. pylori was positive by culture in 88 (26.34%) patients. The concordance of RUT and culture was strong (K= 0.805), and between histology and culture was moderate (K= 0.763) as well as for the gold standard defined and culture (K= 0.80).

Conclusions: We present evidence that RUT and histological methods will be better interpreted for diagnosis of H. pylori if combined with bacterial isolation in cholesterol enriched culture.

How to Cite
Rojas-Rengifo DF, Mendoza B, Jaramillo C, Rodríguez-Urrego PA, Vera-Chamorro JF, Alvarez J, Delgado M del P, Jimenez-Soto LF (2019) Helicobacter pylori culture as a key tool for diagnosis in Colombia. J Infect Dev Ctries 13:720-726. doi: 10.3855/jidc.10720
Original Articles